Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+10.74%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$84.7B
AUM Growth
+$3.15B
(+3.9%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,551
New
35
Increased
617
Reduced
853
Closed
517
Top Buys
| 1 |
L3Harris
LHX
|
+$119M |
| 2 |
Danaher
DHR
|
+$116M |
| 3 |
Zebra Technologies
ZBRA
|
+$111M |
| 4 |
West Pharmaceutical
WST
|
+$87.2M |
| 5 |
Assurant
AIZ
|
+$87M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$196M |
| 2 |
Microsoft
MSFT
|
+$189M |
| 3 |
Merck
MRK
|
+$147M |
| 4 |
Mastercard
MA
|
+$130M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$124M |
Sector Composition
| 1 | Technology | 21.39% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
UDR
UDR
$12.8B
| $56.4M | 0.07% |
1,458,055
-49,155
| -3% | -$1.9M |
|
402
Cencora
COR
$57.7B
| $56.4M | 0.07% |
340,432
-16,701
| -5% | -$2.77M |
|
403
Ionis Pharmaceuticals
IONS
$10.3B
| $56.3M | 0.07% |
1,491,687
+657,646
| +79% | +$24.8M |
|
404
Consensus Cloud Solutions
CCSI
$515M
| $56.2M | 0.07% |
1,045,781
+26,914
| +3% | +$1.45M |
|
405
First Bancorp
FBNC
$2.3B
| $56M | 0.07% |
1,307,466
+34,386
| +3% | +$1.47M |
|
406
Otis Worldwide
OTIS
$34.3B
| $55.9M | 0.07% |
712,963
-32,871
| -4% | -$2.58M |
|
407
MACOM Technology Solutions
MTSI
$9.7B
| $55.5M | 0.07% |
881,431
+56,595
| +7% | +$3.56M |
|
408
Deckers Outdoor
DECK
$17.1B
| $55.5M | 0.07% |
833,676
+556,548
| +201% | +$37M |
|
409
Dana Inc
DAN
$2.72B
| $55.4M | 0.07% |
3,659,047
+73,307
| +2% | +$1.11M |
|
410
Valero Energy
VLO
$48.9B
| $55.3M | 0.07% |
435,731
+27,663
| +7% | +$3.51M |
|
411
Choice Hotels
CHH
$5.31B
| $55.2M | 0.07% |
489,624
+29,150
| +6% | +$3.28M |
|
412
DiamondRock Hospitality
DRH
$1.73B
| $55.1M | 0.07% |
6,738,918
+147,096
| +2% | +$1.2M |
|
413
Lockheed Martin
LMT
$107B
| $55M | 0.06% |
112,980
-21,557
| -16% | -$10.5M |
|
414
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $54.9M | 0.06% |
+1,134,785
| New | +$54.9M |
|
415
Ulta Beauty
ULTA
$23.3B
| $54.7M | 0.06% |
116,565
-185,159
| -61% | -$86.9M |
|
|
ARNC
416
DELISTED
Arconic Corporation
ARNC
| $54.5M | 0.06% |
2,577,945
-111,032
| -4% | -$2.35M |
|
417
Healthpeak Properties
DOC
$12.7B
| $54.4M | 0.06% |
978,576
-1,237,485
| -56% | -$68.8M |
|
|
AZPN
418
DELISTED
Aspen Technology Inc
AZPN
| $54.4M | 0.06% |
264,671
-116,326
| -31% | -$23.9M |
|
419
Azenta
AZTA
$1.35B
| $54M | 0.06% |
928,281
-1,312,973
| -59% | -$76.4M |
|
420
Stewart Information Services
STC
$2.1B
| $53.5M | 0.06% |
1,251,988
+60,450
| +5% | +$2.58M |
|
421
Ligand Pharmaceuticals
LGND
$3.23B
| $53.5M | 0.06% |
800,596
-471,578
| -37% | -$31.5M |
|
422
Crown Castle
CCI
$40.9B
| $53.5M | 0.06% |
395,491
+53,861
| +16% | +$7.28M |
|
423
Boston Scientific
BSX
$160B
| $53.2M | 0.06% |
1,149,160
+98,150
| +9% | +$4.54M |
|
424
Visteon
VC
$3.51B
| $53.1M | 0.06% |
405,933
-32,327
| -7% | -$4.23M |
|
425
Wendy's
WEN
$1.89B
| $53M | 0.06% |
2,340,738
+34,876
| +2% | +$789K |
|